Literature DB >> 11369185

Efficient non-viral DNA-mediated gene transfer to human primary myoblasts using electroporation.

E Espinos1, J H Liu, C R Bader, L Bernheim.   

Abstract

Gene transfer of human primary myoblasts with various non-viral methods has been hampered by low yield of transfection. We report here an efficient, simple and reproducible non-viral DNA-mediated gene transfer procedure for transfecting human myoblasts. We found that electroporation promotes a highly efficient DNA uptake by human primary cultures of myogenic cells. Under optimal conditions, 60-70% of human myoblasts transfected with the enhanced green fluorescent gene expressed the enhanced green fluorescent protein. Electroporated myoblasts behaved normally as judged by their ability to synthesize and express developmentally regulated proteins and to undergo terminal differentiation, i.e. to fuse and form myotubes. We showed, in addition, that a subpopulation of cultured human myoblasts with self-renewing properties and equivalent to native muscle satellite cells were as efficiently transfected by electroporation as proliferating myoblasts. Thus, the development of gene therapies based on the engineering and transplantation of human myoblasts may greatly benefit from gene transfer by electroporation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369185     DOI: 10.1016/s0960-8966(00)00204-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Human myoblast fusion requires expression of functional inward rectifier Kir2.1 channels.

Authors:  J Fischer-Lougheed; J H Liu; E Espinos; D Mordasini; C R Bader; D Belin; L Bernheim
Journal:  J Cell Biol       Date:  2001-05-14       Impact factor: 10.539

2.  Improved CRISPR/Cas9 gene editing in primary human myoblasts using low confluency cultures on Matrigel.

Authors:  Hayley Goullée; Rhonda L Taylor; Alistair R R Forrest; Nigel G Laing; Gianina Ravenscroft; Joshua S Clayton
Journal:  Skelet Muscle       Date:  2021-09-22       Impact factor: 4.912

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.